Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

INTRODUCTION: Iron deficiency anemia (IDA) is common in patients with gastrointestinal (GI) disorders and can adversely affect quality of life. Oral iron is poorly tolerated in many patients with GI disorders. Ferumoxytol is approved for the intravenous treatment of IDA in patients with chronic kidn...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, David C, Dahl, Naomi V, Strauss, William E, Barish, Charles F, Hetzel, David J, Bernard, Kristine, Li, Zhu, Allen, Lee F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946860/
https://www.ncbi.nlm.nih.gov/pubmed/27468245
http://dx.doi.org/10.2147/CEG.S101473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946860/
https://www.ncbi.nlm.nih.gov/pubmed/27468245
http://dx.doi.org/10.2147/CEG.S101473

Ejemplares similares